샘플 요청 목록

 카트 문의
시장보고서
상품코드
1779860

세계의 조영초음파 시장

Contrast Enhanced Ultrasound
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 359 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 조영초음파 시장은 2030년까지 27억 달러에 도달

2024년에 21억 달러로 추정되는 세계의 조영초음파 시장은 2024-2030년에 CAGR 4.2%로 성장하며, 2030년에는 27억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 초음파 장비는 CAGR 5.1%를 기록하며, 분석 기간 종료시에는 16억 달러에 달할 것으로 예측됩니다. 초음파 조영제 부문의 성장률은 분석 기간에 CAGR 3.0%로 추정됩니다.

미국 시장은 5억 7,070만 달러로 추정, 중국은 CAGR 7.8%로 성장 예측

미국의 조영초음파 시장은 2024년에 5억 7,070만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR을 7.8%로 2030년까지 5억 5,270만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.6%와 3.2%로 예측됩니다. 유럽에서는 독일이 CAGR 2.4%로 성장할 것으로 예측됩니다.

세계의 조영초음파 시장 동향과 시장 성장 촉진요인

의료 영상 진단에서 조영제 초음파가 점점 더 중요해지는 이유는 무엇인가?

조영제 초음파는 CT나 MRI와 같은 전통적인 영상 진단법을 대체하여 보다 안전하고 비용 효율적이며 상세한 진단법을 제공함으로써 의료 영상 진단 분야를 빠르게 변화시키고 있습니다. 마이크로 버블 조영제를 사용하여 이 기술은 혈류, 혈관 구조, 조직 관류에 대한 가시성을 강화하여 다양한 임상 용도에서 진단 정확도를 크게 향상시킬 수 있습니다. 유사한 조직 밀도를 구별하는 데 어려움을 겪는 기존 초음파와 달리, 조영 초음파는 더 높은 감도로 실시간 영상을 제공하므로 종양, 염증, 허혈 부위 등의 이상을 보다 정확하게 감지할 수 있습니다.

조영제 초음파의 채택을 촉진하는 주요 요인 중 하나는 안전성 프로파일입니다. CT와 MRI 검사에 사용되는 기존의 조영제는 요오드나 가돌리늄을 함유하고 있으며, 특히 신장 기능 장애가 있는 환자에게는 알레르기 반응이나 신독성 위험이 있습니다. 반면, 마이크로버블 기반의 초음파 조영제는 생물학적으로 불활성이며 체내에서 빠르게 배출되어 안전성이 뛰어납니다. 또한 조영제 초음파 검사는 전리방사선을 포함하지 않기 때문에 소아 및 임산부 환자에게 선호되는 검사법입니다. 비침습적이고 방사선을 사용하지 않는 영상 진단 솔루션에 대한 수요가 증가하고 있으며, 조영제 초음파는 현대의 진단 워크플로우에서 중요한 툴이 되고 있습니다.

기술 발전은 어떻게 조영제 초음파를 향상시키고 있는가?

초음파 영상 기술의 발전으로 조영 초음파의 기능과 정확도가 크게 향상되어 다양한 병태의 검출 및 특성화가 더욱 효과적으로 이루어지고 있습니다. 가장 주목할 만한 혁신 중 하나는 실시간 관류 영상 개발로, 임상의가 미세혈관의 혈류 동역학을 평가하고 조직과 장기의 이상을 보다 정확하게 파악할 수 있게 되었습니다. 이는 종양학에서 특히 유용하며, 종양 혈관의 가시성을 강화하여 양성 병변과 악성 병변을 구별하고 암을 조기에 발견하고 치료 계획을 세우는 데 도움을 줄 수 있습니다.

또 다른 중요한 발전은 조영술 초음파 분석에 인공지능과 머신러닝을 통합한 것입니다. AI 기반 이미지 해석 알고리즘은 관류 패턴의 변화를 자동으로 감지하고 정량화하여 작업자의 의존도를 줄이고 진단의 일관성을 향상시킬 수 있습니다. 또한 차세대 초음파 장비는 더 높은 공간 해상도, 향상된 고조파 이미징, 향상된 도플러 기능을 갖추고 있으며, 조영제 초음파의 혈류 및 조직 관류 시각화 능력을 더욱 향상시켰습니다. 이러한 기술 개선으로 조영초음파는 정밀의료에 필수적인 툴로 자리매김하고 있으며, 다양한 병증에 맞는 영상 솔루션을 제공합니다.

조영제 초음파의 주요 산업 용도는?

조영제 초음파는 임상의가 질병을 진단하고 모니터링하는 방식에 혁명을 가져왔으며, 여러 의료 전문 분야에서 점점 더 많이 사용되고 있습니다. 주요 용도 중 하나는 간 병리학에서 간 병변, 간경변, 간 관류 이상 평가에 사용됩니다. 조영 초음파 검사는 양성 간종양과 악성 간종양을 구별할 수 있으며, 특히 만성 간질환 환자를 대상으로 한 간암 검진에서 선호되는 영상 진단법입니다. 또한 간세포암 환자의 간 생검 유도 및 치료 효과 모니터링에도 중요한 역할을 하고 있습니다.

심장병학에서 조영 초음파 검사는 심근 관류 평가, 허혈성 심장질환의 발견, 심장 기능 평가에 널리 사용됩니다. 조영 초음파 검사는 미세혈관의 혈류를 시각화하여 심장 전문의가 표준 심초음파 검사로는 볼 수 없는 미세한 관류 장애를 감지하는 데 도움을 줍니다. 조영 초음파는 신장병학에서도 신장질환의 진단, 신장 관류 평가, 혈관 이상 발견에 도움이 되고 있습니다. 다른 새로운 용도로는 유방암, 전립선암, 췌장암을 검출하는 종양학, 염증 상태 및 연조직의 혈관 형성을 평가하는 근골격계 영상이 있습니다. 의료계가 조영 초음파의 장점을 계속 인식함에 따라 그 사용은 다양한 진단 및 중재 시술로 확대되고 있습니다.

조영제 초음파 시장의 성장을 가속하는 요인은 무엇인가?

조영 초음파 시장의 성장은 비침습적 영상 기술에 대한 수요 증가, 초음파 기술의 발전, 상세한 혈관 평가가 필요한 만성질환의 유병률 증가 등 여러 가지 요인에 기인합니다. 의료 서비스 프로바이더들이 CT와 MRI를 대체할 수 있는 안전하고 비용 효율적인 방법을 찾고 있는 가운데, 조영제 초음파는 방사선이 필요 없고 진단 정확도가 높아 선호되는 영상 진단 방법으로 부상하고 있습니다. 간 질환, 심혈관 질환, 암 발병률 증가는 첨단 영상 솔루션의 필요성을 더욱 가속화시키고 있으며, 조영제 초음파는 질병을 감지하고 관리하는 데 있으며, 중요한 툴로 자리매김하고 있습니다.

인공지능과 실시간 이미지 분석의 통합은 조영제 초음파 판독의 정확성과 효율성을 높이는 주요 촉진제입니다. 또한 응급의료, 중증환자, 외래환자 등에서 폭넓은 활용이 가능한 휴대용 초음파 진단기기 및 현장진단용 초음파 진단기기의 채택이 증가하고 있는 것도 시장 성장을 촉진하고 있습니다. 또한 조영제 초음파 검사에 대한 규제 당국의 승인 및 급여 정책의 확대도 의료 서비스 프로바이더의 채택 확대를 촉진하고 있습니다. 실시간 고해상도 영상에 대한 수요가 지속적으로 증가하는 가운데, 조영제 초음파는 현대 의료 진단에 필수적인 존재가 되어 다양한 임상 용도에서 보다 빠르고 안전하며 정밀한 영상 솔루션을 제공합니다.

부문

제품 유형(초음파 장비, 초음파 조영제); CEUS 유형(비표적 CEUS, 표적 CEUS); 최종 사용(병원 최종 사용, 진료소 최종 사용, 외래 진단 센터 최종 사용)

조사 대상 기업의 예

  • Acusphere Inc.
  • Alpinion Medical Systems
  • BK Medical Holding Company Inc.
  • Bracco Diagnostic Inc.
  • Canon Medical Systems Corporation
  • Chison Medical Technology Co., Ltd.
  • ContextVision AB
  • Esaote S.p.A.
  • FUJIFILM VisualSonics Inc.
  • GE Healthcare
  • Hitachi Healthcare
  • Koninklijke Philips N.V.
  • Lantheus Medical Imaging, Inc.
  • Leriva Pharma S.A.
  • nanoPET Pharma GmbH
  • Samsung Healthcare
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers
  • Trivitron Healthcare Pvt. Ltd.

AI 통합

당사는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계 고유 SLM를 쿼리 하는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.06

Global Contrast Enhanced Ultrasound Market to Reach US$2.7 Billion by 2030

The global market for Contrast Enhanced Ultrasound estimated at US$2.1 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Ultrasound Equipment, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Ultrasound Contrast Agents segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$570.7 Million While China is Forecast to Grow at 7.8% CAGR

The Contrast Enhanced Ultrasound market in the U.S. is estimated at US$570.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$552.7 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Contrast-Enhanced Ultrasound Market - Trends, Innovations & Growth Drivers

Why Is Contrast-Enhanced Ultrasound Gaining Importance in Medical Imaging?

Contrast-enhanced ultrasound is rapidly transforming the field of medical imaging, offering a safer, cost-effective, and highly detailed diagnostic alternative to traditional imaging modalities such as CT and MRI. By using microbubble contrast agents, this technology enhances the visualization of blood flow, vascular structures, and tissue perfusion, significantly improving diagnostic accuracy in various clinical applications. Unlike conventional ultrasound, which often struggles to differentiate between similar tissue densities, contrast-enhanced ultrasound provides real-time imaging with higher sensitivity, allowing for better detection of abnormalities such as tumors, inflammation, and ischemic regions.

One of the major factors driving the adoption of contrast-enhanced ultrasound is its safety profile. Traditional contrast agents used in CT and MRI scans contain iodine and gadolinium, which pose risks of allergic reactions and nephrotoxicity, especially in patients with kidney dysfunction. In contrast, microbubble-based ultrasound contrast agents have an excellent safety record, as they are biologically inert and quickly eliminated from the body. Additionally, contrast-enhanced ultrasound does not involve ionizing radiation, making it a preferred choice for pediatric and pregnant patients. The demand for non-invasive, radiation-free imaging solutions is increasing, making contrast-enhanced ultrasound a valuable tool in modern diagnostic workflows.

How Are Technological Advancements Enhancing Contrast-Enhanced Ultrasound?

Advancements in ultrasound imaging technology have significantly improved the capabilities and accuracy of contrast-enhanced ultrasound, making it more effective in detecting and characterizing various pathologies. One of the most notable innovations is the development of real-time perfusion imaging, which allows clinicians to assess microvascular blood flow dynamics and identify abnormalities in tissues and organs with greater precision. This is particularly useful in oncology, where enhanced visualization of tumor vascularity can help differentiate between benign and malignant lesions, aiding in early cancer detection and treatment planning.

Another key advancement is the integration of artificial intelligence and machine learning in contrast-enhanced ultrasound analysis. AI-driven image interpretation algorithms can automatically detect and quantify changes in perfusion patterns, reducing operator dependency and improving diagnostic consistency. Additionally, new-generation ultrasound machines feature higher spatial resolution, improved harmonic imaging, and enhanced Doppler capabilities, further refining contrast-enhanced ultrasound’s ability to visualize blood flow and tissue perfusion. With these technological improvements, contrast-enhanced ultrasound is becoming an essential tool in precision medicine, offering tailored imaging solutions for various medical conditions.

What Are the Key Industry Applications of Contrast-Enhanced Ultrasound?

Contrast-enhanced ultrasound is being increasingly utilized across multiple medical specialties, revolutionizing the way clinicians diagnose and monitor diseases. One of the primary applications is in hepatology, where it is used to assess liver lesions, cirrhosis, and hepatic perfusion abnormalities. The ability of contrast-enhanced ultrasound to differentiate between benign and malignant liver tumors has made it a preferred imaging method in liver cancer screening, particularly for patients with chronic liver disease. Additionally, it plays a critical role in guiding liver biopsies and monitoring treatment response in hepatocellular carcinoma patients.

In cardiology, contrast-enhanced ultrasound is widely used for evaluating myocardial perfusion, detecting ischemic heart disease, and assessing cardiac function. By enhancing the visualization of microvascular blood flow, it helps cardiologists detect subtle perfusion defects that may not be visible on standard echocardiography. Contrast-enhanced ultrasound is also gaining traction in nephrology, where it assists in diagnosing kidney diseases, assessing renal perfusion, and detecting vascular abnormalities. Other emerging applications include oncology, where it aids in the detection of breast, prostate, and pancreatic cancers, as well as musculoskeletal imaging for evaluating inflammatory conditions and soft tissue vascularization. As the medical community continues to recognize the advantages of contrast-enhanced ultrasound, its use is expanding across various diagnostic and interventional procedures.

What Factors Are Driving Growth in the Contrast-Enhanced Ultrasound Market?

The growth in the contrast-enhanced ultrasound market is driven by several factors, including increasing demand for non-invasive imaging techniques, advancements in ultrasound technology, and the growing prevalence of chronic diseases requiring detailed vascular assessment. As healthcare providers seek safer and more cost-effective alternatives to CT and MRI, contrast-enhanced ultrasound is emerging as a preferred imaging modality due to its radiation-free nature and high diagnostic accuracy. The rising incidence of liver disease, cardiovascular disorders, and cancer has further accelerated the need for advanced imaging solutions, positioning contrast-enhanced ultrasound as a critical tool in disease detection and management.

Another key driver is the integration of artificial intelligence and real-time image analysis, which is enhancing the accuracy and efficiency of contrast-enhanced ultrasound interpretation. The increasing adoption of portable and point-of-care ultrasound systems is also fueling market growth, allowing for broader accessibility in emergency medicine, critical care, and outpatient settings. Additionally, regulatory approvals and expanded reimbursement policies for contrast-enhanced ultrasound procedures are encouraging greater adoption among healthcare providers. As the demand for real-time, high-resolution imaging continues to grow, contrast-enhanced ultrasound is set to become an indispensable part of modern medical diagnostics, providing faster, safer, and more precise imaging solutions across a wide range of clinical applications.

SCOPE OF STUDY:

The report analyzes the Contrast Enhanced Ultrasound market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Ultrasound Equipment, Ultrasound Contrast Agents); CEUS Type (Non-Targeted CEUS, Targeted CEUS); End-Use (Hospitals End-Use, Clinics End-Use, Ambulatory Diagnostic Centers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Acusphere Inc.
  • Alpinion Medical Systems
  • BK Medical Holding Company Inc.
  • Bracco Diagnostic Inc.
  • Canon Medical Systems Corporation
  • Chison Medical Technology Co., Ltd.
  • ContextVision AB
  • Esaote S.p.A.
  • FUJIFILM VisualSonics Inc.
  • GE Healthcare
  • Hitachi Healthcare
  • Koninklijke Philips N.V.
  • Lantheus Medical Imaging, Inc.
  • Leriva Pharma S.A.
  • nanoPET Pharma GmbH
  • Samsung Healthcare
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers
  • Trivitron Healthcare Pvt. Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Contrast Enhanced Ultrasound - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Liver, Kidney, and Cardiovascular Diseases Drives Clinical Adoption of CEUS
    • Radiation-Free Imaging Alternatives Strengthen the Business Case for Contrast-Enhanced Ultrasound Over CT and MRI
    • Increased Use of CEUS in Oncology Supports Demand for Real-Time, Non-Invasive Tumor Characterization
    • FDA and EMA Approvals for New Contrast Agents Expand Clinical Applications Across Regions
    • Advancements in Microbubble Contrast Agents Enhance Image Resolution and Diagnostic Accuracy
    • Growing Awareness Among Radiologists and Sonographers Boosts Utilization Rates in Hospitals and Imaging Centers
    • Demand for Bedside and Point-of-Care Diagnostics Propels CEUS Use in Emergency and Critical Care Settings
    • Pediatric and Pregnant Patient Populations Drive Need for Safer, Non-Ionizing Imaging Modalities
    • Healthcare Cost Optimization Goals Promote CEUS as a Lower-Cost Alternative to Cross-Sectional Imaging
    • Clinical Expansion Into Cardiac, Vascular, and GI Imaging Broadens the CEUS Use Case Portfolio
    • OEM Innovations in Ultrasound Systems With CEUS Capabilities Improve Workflow Integration
    • CEUS-Guided Biopsies and Interventional Procedures Enhance Clinical Outcomes and Expand Adoption
    • Increased Use in Chronic Disease Management and Monitoring Drives Repeat Imaging Demand
    • Supportive Reimbursement Structures in Europe and Select U.S. States Accelerate Institutional Adoption
    • Growing Preference for Portable and Handheld Ultrasound Devices Expands CEUS Accessibility
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Contrast Enhanced Ultrasound Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Contrast Enhanced Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Contrast Enhanced Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ultrasound Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Ultrasound Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Ultrasound Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Ultrasound Contrast Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Ultrasound Contrast Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Ultrasound Contrast Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Non-Targeted CEUS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Non-Targeted CEUS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Non-Targeted CEUS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Targeted CEUS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Targeted CEUS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Targeted CEUS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Ambulatory Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Contrast Enhanced Ultrasound by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Contrast Enhanced Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Germany 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Italy 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 101: UK Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Spain 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Russia Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Russia 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Australia Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Australia 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 158: India Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: India Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: India 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 161: India Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: South Korea Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: South Korea 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 186: Latin America Historic Review for Contrast Enhanced Ultrasound by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 197: Argentina Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Argentina Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Argentina 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Brazil Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Brazil 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Mexico Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Mexico 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Rest of Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 234: Middle East Historic Review for Contrast Enhanced Ultrasound by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 245: Iran Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Iran Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Iran 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 254: Israel Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Israel Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Israel 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Saudi Arabia Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Saudi Arabia 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 272: UAE Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: UAE Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: UAE 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Rest of Middle East Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Rest of Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 290: Africa Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Africa Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Africa 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제